Determinants of the Over-Anticoagulation Response during Warfarin Initiation Therapy in Asian Patients Based on Population Pharmacokinetic-Pharmacodynamic Analyses

• Minami Ohara,

  Affiliation Department of Biopharmaceutics, Meiji Pharmaceutical University, Tokyo, Japan

  ⨯
• Harumi Takahashi ,

  * E-mail: harumit@my-pharm.ac.jp

  Affiliation Department of Biopharmaceutics, Meiji Pharmaceutical University, Tokyo, Japan

  ⨯
• Ming Ta Michael Lee,

  Affiliations Laboratory for International Alliance on Genomic Research, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

  ⨯
• Ming-Shien Wen,

  Affiliation Departments of Medicine and Neurology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan

  ⨯
• Tsong-Hai Lee,

  Affiliation Departments of Medicine and Neurology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan

  ⨯
• Hui-Ping Chuang,

  Affiliation Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

  ⨯
• Chen-Hui Luo,

  Affiliation Department of Biopharmaceutics, Meiji Pharmaceutical University, Tokyo, Japan

  ⨯
• Aki Arima,

  Affiliation Department of Biopharmaceutics, Meiji Pharmaceutical University, Tokyo, Japan

  ⨯
• Akiko Onozuka,

  Affiliation Department of Biopharmaceutics, Meiji Pharmaceutical University, Tokyo, Japan

  ⨯
• Rui Nagai,

  Affiliation Department of Biopharmaceutics, Meiji Pharmaceutical University, Tokyo, Japan

  ⨯
• Mari Shiomi,

  Affiliation Department of Biopharmaceutics, Meiji Pharmaceutical University, Tokyo, Japan

  ⨯
• Kiyoshi Mihara,

  Affiliation Faculty of Pharmacy, Center for Clinical Pharmacy, Musashino University, Tokyo, Japan

  ⨯
• Takashi Morita,

  Affiliation School of Medicine, Juntendo University, Tokyo, Japan

  ⨯
• Yuan-Tsong Chen

  Affiliation Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

  ⨯